112
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Cathepsins: Novel Drug Targets for Cardiovascular diseases?

Pages 563-565 | Published online: 15 Sep 2005

Bibliography

  • Sukhova GK, Shi GP, Simon DI et al.: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest., 102, 576–583 (1998).
  • Shi GP, Sukhova GK, Kuzuya M et al.: Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ. Res., 92, 493–500 (2003).
  • Punturieri A, Filippov S, Allen E et al.: Regulation of elastinolytic cysteine protease activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med., 192, 789–799 (2000).
  • Shi GP, Sukhova GK, Grubb A et al.: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest., 104, 1191–1197 (1999).
  • Liu J, Sukhova GK, Yang JT et al.: Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis (2005) Jun 24 [Epub ahead of print].
  • Sukhova GK, Zhang Y, Pan JH et al.: Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest., 111, 897–906 (2003).
  • Sukhova GK, Wang B, Libby P et al.: Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ. Res., 96, 368–375 (2005).
  • Cannon CP, Braunwald E, McCabe CH et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med., 350, 1495–1504 (2004).
  • Shi GP, Chapman HA, Bhairi SM et al.: Molecular cloning of human cathepsin O, a novel endoprotease and homologue of rabbit OC2. FEBS Lett., 357, 129–134 (1995).
  • Gelb BD, Shi GP, Chapman HA et al.: Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science, 273, 1236–1238 (1996).
  • Saftig P, Hunziker E, Wehmeyer O et al.: Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl Acad. Sci. USA, 95, 13453–13458 (1998).
  • James IE, Marquis RW, Blake SM et al.: Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro. J. Biol. Chem., 276, 11507–11511 (2001).
  • Shi GP, Villadangos JA, Dranoff G et al.: Cathepsin S required for normal MHC Class II peptide loading and germinal center development. Immunity, 10, 197–206 (1999).
  • Nakagawa T, Roth W, Wong P et al.: Cathepsin L: critical role in Ii degradation and CD4 T-cell selection in the thymus. Science, 280, 450–453 (1998).
  • Benavides F, Starost MF, Flores M et al.: Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation. Am. J. Pathol., 161, 693–703 (2002).
  • Stypmann J, Glaser K, Roth W et al.: Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc. Natl Acad. Sci. USA, 99, 6234–6239 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.